Identification of a Novel Heart-Liver Axis: Matrix Metalloproteinase-2 Negatively Regulates Cardiac Secreted Phospholipase A2 to Modulate Lipid Metabolism and Inflammation in the Liver. [electronic resource]
Producer: 20160912ISSN:- 2047-9980
- Acetates -- pharmacology
- Animals
- Antibodies -- pharmacology
- Cells, Cultured
- Chemokine CCL7 -- antagonists & inhibitors
- Cholesterol, Dietary -- metabolism
- Enzyme Inhibitors -- pharmacology
- Gene Expression Regulation
- Genetic Predisposition to Disease
- Hepatitis -- enzymology
- Indoles -- pharmacology
- Keto Acids
- Lipid Metabolism -- drug effects
- Liver -- drug effects
- Matrix Metalloproteinase 2 -- deficiency
- Mice, Inbred C57BL
- Mice, Knockout
- Myocytes, Cardiac -- drug effects
- Phenotype
- Phospholipases A2, Secretory -- antagonists & inhibitors
- Signal Transduction
- Time Factors
- Transcription, Genetic
- Triglycerides -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.